Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 710 participants.
Also called NCT04606576
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 710 participants
- Sponsor
- Registry
-
NCT04606576
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT04606576. Randomized; quadruple masking; primary purpose treatment. Start 2020-12-15 (actual); primary completion 2023-01-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Other)
- Placebo
- Intervention (Drug)
- ORMD-0801 QD
- Intervention (Drug)
- ORMD-0801 BD
- Lead sponsor
- Oramed, Ltd.
- Collaborator
- Integrium
Record details
- Record id
cardio:ct-nct04606576- Content hash
15df71106314088aaf17112ce6872cea1515cfcee9663f9d15815744978fd967